American Society of Hematology

SHERPA: Blue

People

  1. Devlin
    Devlin
  2. Levine
    Levine
  3. Tallman
    Tallman
  4. Hassoun
    Hassoun
  5. Arango Ossa
    Arango Ossa
  6. Fleisher
    Fleisher
  7. Abdel-Wahab
    Abdel-Wahab
  8. Drake
    Drake
  9. Papaemmanuil
    Papaemmanuil
  10. Rampal
    Rampal

Groups

  1. Adult Leukemia (54)
  2. Center for Hematologic Malignancies (54)
  3. Department of Medicine (54)
  4. Hematologic Malignancies, Division of (54)
  5. Executive Committee, Center for Hematologic Malignancies (17)
  6. GSK Faculty (17)
  7. Center for Molecular Imaging and Biotechnology (CMIB) (15)
  8. Department of Pathology and Laboratory Medicine (15)
  9. Epidemiology and Biostatistics (14)
  10. Hematology-Oncology Fellows (11)
Search Within
  1. "Virginia Klimek"
Formats
  1. Meeting Abstract (45)
  2. Journal Article (9)
Groups
  1. Adult Leukemia (54)
  2. Center for Hematologic Malignancies (54)
  3. Department of Medicine (54)
  4. Hematologic Malignancies, Division of (54)
  5. Executive Committee, Center for Hematologic Malignancies (17)
  6. GSK Faculty (17)

More Groups

People
  1. Virginia Klimek (54)
  2. Stephen Nimer (20)
  3. Sean Devlin (10)
  4. Martin Tallman (9)
  5. Raymond Comenzo (9)
  6. Ross Levine (9)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (1)
  4. 2020 (2)
  5. 2019 (5)
  6. 2018 (2)

More Years

Publications
  1. Blood (54)

Results (54)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Molecular and clinical presentation of UBA1-mutated myelodysplastic syndromes
    Journal Article

    Sirenko, M.; Bernard, E.; Creignou, M.; Domenico, D.; Farina, A.; Arango Ossa, J. E.; Kosmider, O.; Hasserjian, R.; Jädersten, M.; Germing, U.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Molecular taxonomy of myelodysplastic syndromes and its clinical implications
    Meeting Abstract

    Bernard, E.; Hasserjian, R.; Greenberg, P. L.; Ossa, J. E. A.; Creignou, M.; Nannya, Y.; Tuechler, H.; Medina-Martínez, J. S.; Levine, M. F.; Jädersten, M.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • UBA1 mutations identify a rare but distinct subtype of myelodysplastic syndromes
    Meeting Abstract

    Sirenko, M.; Bernard, E.; Creignou, M.; Domenico, D.; Farina, A.; Ossa, J. E. A.; Kosmider, O.; Hasserjian, R.; Jädersten, M.; Germing, U.; more...
    Blood (2023)

    Fulltext@MSK | Save
  • Incidence, clinical associations, and co-mutation patterns of UBA1 mutations in MDS
    Meeting Abstract

    Sirenko, M.; Bernard, E.; Beck, D. B.; Creignou, M.; Domenico, D.; Farina, A.; Arango, J. E.; Kosmider, O.; Hasserjian, R. P.; Jadersten, M.; more...
    Blood (2022)

    Fulltext@MSK | Save
  • Immunophenotypic lineage assessment by multiparameter flow cytometry provides more precise MDS prognosis
    Meeting Abstract

    Onyekwere, I.; Garcia, J. P.; Menghrajani, K.; Chan, A.; Famulare, C.; Patel, M. A.; Philip, J.; Tallman, M. S.; Klimek, V. M.; Levine, R. L.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Interplay between chromosomal alterations and gene mutations shapes the evolutionary trajectory of clonal hematopoiesis
    Meeting Abstract

    Gao, T.; Ptashkin, R.; Bolton, K. L.; Fong, C.; Spitzer, B.; Menghrajani, K.; Arango Ossa, J. E.; Zhou, Y.; Bernard, E.; Levine, M.; more...
    Blood (2020)

    Fulltext@MSK | Save
  • Preliminary results from a phase II study of the combination of pevonedistat and azacitidine in the treatment of MDS and MDS/MPN after failure of DNA methyltransferase inhibition
    Meeting Abstract

    Moyo, T. K.; Watts, J. M.; Skikne, B. S.; Mendler, J. H.; Klimek, V. M.; Chen, S. C.; Fan, R.; Anderson, I. A.; Sochacki, A.; Strickland, S. A.; more...
    Blood (2019)

    Fulltext@MSK | Save
  • Choice of hypomethylating agent (HMA) for initial treatment does not influence outcome or survival for therapy-related myeloid neoplasms (t-MN)
    Meeting Abstract

    Kabel, C. C.; Goldman, D. A.; Buie, L. W.; Klimek, V. M.
    Blood (2019)

    Fulltext@MSK | Save
  • Plasmacytoid dendritic cell proportion is predictive of risk and outcomes in myelodysplastic syndromes
    Meeting Abstract

    Chan, A.; Zhang, Y.; Devlin, S. M.; Lewis, N.; Baik, J.; Arcila, M. E.; Klimek, V. M.; Roshal, M.; Xiao, W.
    Blood (2019)

    Fulltext@MSK | Save
  • Results of a clinical trial of H3B-8800, a splicing modulator, in patients with myelodysplastic syndromes (MDS), acute myeloid leukemia (AML) or chronic myelomonocytic leukemia (CMML)
    Meeting Abstract

    Steensma, D. P.; Wermke, M.; Klimek, V. M.; Greenberg, P. L.; Font, P.; Komrokji, R. S.; Yang, J.; Brunner, A. M.; Carraway, H. E.; Ades, L.; more...
    Blood (2019)

    Fulltext@MSK | Save